<62D1A5A9CD0DD511AE6B00AA00DD611F25DEC8@exstaff2.city.unisa.edu.au>
Sender: owner-e-drug@usa.healthnet.org
Precedence: bulk
E-drug: Re: Strategies for Pharmaceutical Cost Containment (cont)
-------------------------------------------------------------------------
Dear Dave,
I wonder if it would not be more helpful to reframe your question about
pharmaceuticals into a debate on how we maintain equitable access to
medicines and rational drug use as the primary goal, and indirectly
"cost-containment" for the purposes of maintaining equitable access (rather
than the other way around). I would also suggest that in your approach to
dealing with these issues that a National Medicinal Drug Policy and a
national and co-ordinated approach to improving use of medicines are
themselves approaches to these issues, within which your strategies 1 to 8
below could be incorporated
Good luck
Libby Roughead
School of Pharmaceutical, Molecular and Biomedical Sciences
University of South Australia
North Terrace
Adelaide 5000
South Australia
Australia
Ph +61 8 8302 2179
Fax + 61 8 8302 2389
E-mail: libby.roughead@unisa.edu.au
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.